Published on in Vol 3, No 4 (2019): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/13286, first published .
Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis

Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis

Passive Monitoring of Short-Acting Beta-Agonist Use via Digital Platform in Patients With Chronic Obstructive Pulmonary Disease: Quality Improvement Retrospective Analysis

Journals

  1. Fan K, Mandel J, Agnihotri P, Tai-Seale M. Remote Patient Monitoring Technologies for Predicting Chronic Obstructive Pulmonary Disease Exacerbations: Review and Comparison. JMIR mHealth and uHealth 2020;8(5):e16147 View
  2. Mihălțan F, Coșei V, Borcea C, Constantin A. Telemedicine in chronic obstructive pulmonary disease: a possible transition to the patient independence. Pneumologia 2020;69(1):17 View
  3. Cazzola M, Cavalli F, Usmani O, Rogliani P. Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Delivery 2020;17(5):635 View
  4. Kaye L, Gondalia R, Barrett M, Williams M, Stempel D. Concurrent Improvement Observed in Patient-Reported Burden and Sensor-Collected Medication Use Among Patients Enrolled in a COPD Digital Health Program. Frontiers in Digital Health 2021;3 View
  5. Jarrin R, Barrett M, Kaye L, Sayiner S, von Leer A, Johns J, D’Andrea L, Nunez C, Ostrovsky A. Need for clarifying remote physiologic monitoring reimbursement during the COVID-19 pandemic: a respiratory disease case study. npj Digital Medicine 2021;4(1) View